Wyeth To Relinquish Altace Marketing To King At Year-End
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a modified promotion agreement for the ACE inhibitor, King will take over sales and marketing of ramipril effective Jan. 1.
You may also be interested in...
Altace Secret Formulation Not Expected To Be Approved Until First Half Of 2007
Timeline suggests King may receive FDA “approvable” letter.
Altace Secret Formulation Not Expected To Be Approved Until First Half Of 2007
Timeline suggests King may receive FDA “approvable” letter.
King Specialty Cardiovascular/Metabolics Force To Be In Place By September
Second quarter Altace sales up $10 mil. as Wyeth co-promotion winds down.